Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
about
Competing risks modeling of cumulative effects of time-varying drug exposures.Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products.
P2860
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Benefit-Risk Assessment, Commu ...... of the pharmacoepidemiologist.
@en
type
label
Benefit-Risk Assessment, Commu ...... of the pharmacoepidemiologist.
@en
prefLabel
Benefit-Risk Assessment, Commu ...... of the pharmacoepidemiologist.
@en
P2093
P2860
P356
P1476
Benefit-Risk Assessment, Commu ...... of the pharmacoepidemiologist.
@en
P2093
BRACE Special Interest Group
Bennett Levitan
Christine Radawski
Elaine Morrato
Han-Yao Huang
Juhaeri Juhaeri
Kenneth Hornbuckle
Meredith Smith
Priya Bahri
P2860
P304
P356
10.1002/PDS.3859
P577
2015-10-12T00:00:00Z